Govt Job: For M.Pharm, Pharm.D to Join IPC – Indian Pharmacopoeia Commission

The Indian Pharmacopoeia Commission (IPC) is an autonomous institution of the Ministry of Health and Family Welfare, Govt. of India.

IPC is created to set standards for drugs in the country. Its basic function is to update regularly the standards of drugs commonly required for the treatment of diseases prevailing in this region.

It publishes official documents for improving the Quality of Medicines by way of adding new and updating existing monographs in the form of Indian Pharmacopoeia (IP).

It further promotes the rational use of generic medicines by publishing National Formulary of India.

IP prescribes standards for the identity, purity and strength of drugs essentially required from the health care perspective of human beings and animals.

Post: Jr. Pharmacovigilance Associate

Salary : Rs. 26,250 PM
Qualification: Master’s degree in Pharmacy, Clinical Pharmacology, Pharmacy Practice, and Clinical Research.

OR  Pharm.D / MBBS / BDS from a recognised university / Institute

Desirable : 3-6 months of working experience in drug safety / Pharmacovigilance

Age: Not exceeding 28 years

1. Ghaziabad-based Indian Pharmacopoeia Commission (IPC).  

2. The posting as per the requirement of PvPI may be anywhere (AMC/Regional training Centre of PvPI)in India across the country.

Job Description
1. Collection of ADR Reports.

2. Processing of Individual Case Safety Reports (ICSRs) and managing them in VigiFlow.

3. Quality review, Clinical Review & Statistical review of ICSRs in the Drug Safety database.

4. Any other work assigned by the Competent Authority from time to time.

Period of engagement

Initially, the tenure of the contract will be for a period of up to one year through GeM, however, the contract may be renewed further based on the performance of the applicant.

In case the work and conduct of the applicant are not found to be satisfactory during the contract tenure, the services may be terminated at any time without assigning any reason thereof.

General Instructions

1.  Interview will be conducted in Hybrid mode.

It is not obligatory on the part of IPC or Manpower Outsourcing Service Agency to call for an interview with every candidate who possesses the essential qualification.

2. The requirements of minimum qualification, Age and/or experience may be relaxed in the case of candidates with outstanding credentials.

3. The candidate is responsible for the correctness of the information provided in the application.

If it is found at a later stage that any information given in the application is incorrect/false, the candidature/appointment is liable to be cancelled/terminated.

4. Preference may be given to candidates who have desirable experience.

5. Candidates are requested to provide their active email Id/mobile phone numbers/landline phone numbers for easy communication.

6. Candidates shortlisted for interview will have to produce original documents for verification in support of their application educational qualification, and experience at the time of the Interview.

7. The incomplete application will not be entertained.

8. The Competent Authority reserves the right to defer or cancel the selection process at any stage without assigning any reason thereof.

9. No TA/DA shall be paid for attending the interview.

10. The no. of the vacancy will be as per PvPI from time to time.

An updated resume, certificate, and documentary proof should be uploaded along with the application form.

Related Posts

  • Pharma
  • July 3, 2025
  • 91 views
Cipla in talks to add new customers for its China factory, executive says

SHANGHAI – Indian drugmaker Cipla (CIPL.NS), opens new tab is looking to add at least two new overseas markets for its products manufactured in China, as the firm seeks to…

  • Pharma
  • July 3, 2025
  • 77 views
No link between COVID-19 vaccines & sudden deaths: ICMR-AIIMS Study

​Union Minister of Health and Family Welfare said that extensive studies by the Indian Council of Medical Research (ICMR) and All India Institute of Medical Sciences have conclusively established no…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Cipla in talks to add new customers for its China factory, executive says

Cipla in talks to add new customers for its China factory, executive says

No link between COVID-19 vaccines & sudden deaths: ICMR-AIIMS Study

No link between COVID-19 vaccines & sudden deaths: ICMR-AIIMS Study

Delhi High Court asks DGCI to decide on plea against licensing of weight-loss drugs

Delhi High Court asks DGCI to decide on plea against licensing of weight-loss drugs

Microplastics found in brain, ovaries, and placenta: Experts warn of silent threat to vital organs

Microplastics found in brain, ovaries, and placenta: Experts warn of silent threat to vital organs